These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19169164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).
    Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB, Randolph JF, Matthews KA.
    Arch Gen Psychiatry; 2010 Jun; 67(6):598-607. PubMed ID: 20530009
    [Abstract] [Full Text] [Related]

  • 3. Association of sex hormones and sex hormone-binding globulin with depressive symptoms in postmenopausal women: the Multiethnic Study of Atherosclerosis.
    Colangelo LA, Craft LL, Ouyang P, Liu K, Schreiner PJ, Michos ED, Gapstur SM.
    Menopause; 2012 Aug; 19(8):877-85. PubMed ID: 22415566
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
    Randolph JF, Sowers M, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA.
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Follicle-Stimulating Hormone Levels and Subclinical Atherosclerosis in Older Postmenopausal Women.
    Bertone-Johnson ER, Virtanen JK, Nurmi T, Niskanen L, Mursu J, Voutilainen S, Ronkainen K, Kauhanen J, Tuomainen TP.
    Am J Epidemiol; 2018 Jan 01; 187(1):16-26. PubMed ID: 29309514
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Ausmanas MK, Tan DA, Jaisamrarn U, Tian XW, Holinka CF.
    Climacteric; 2007 Oct 01; 10(5):427-37. PubMed ID: 17852146
    [Abstract] [Full Text] [Related]

  • 11. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.
    Slopien R, Pluchino N, Warenik-Szymankiewicz A, Sajdak S, Luisi M, Drakopoulos P, Genazzani AR.
    Gynecol Endocrinol; 2018 Feb 01; 34(2):144-147. PubMed ID: 28857628
    [Abstract] [Full Text] [Related]

  • 12. Maca reduces blood pressure and depression, in a pilot study in postmenopausal women.
    Stojanovska L, Law C, Lai B, Chung T, Nelson K, Day S, Apostolopoulos V, Haines C.
    Climacteric; 2015 Feb 01; 18(1):69-78. PubMed ID: 24931003
    [Abstract] [Full Text] [Related]

  • 13. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I, Albert US, Kalder M, Winarno AS, Hars O, Hadji P.
    Climacteric; 2015 Feb 01; 18(1):63-8. PubMed ID: 24884402
    [Abstract] [Full Text] [Related]

  • 14. Hormone profile of menopausal women in Havana.
    Navarro D, Acosta A, Robles E, Díaz C.
    MEDICC Rev; 2012 Apr 01; 14(2):13-5. PubMed ID: 22580548
    [Abstract] [Full Text] [Related]

  • 15. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
    Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ.
    Cancer Causes Control; 2001 Jan 01; 12(1):47-59. PubMed ID: 11227925
    [Abstract] [Full Text] [Related]

  • 16. Do FSH/LH ratio and gonadal hormone levels predict clinical improvement in postmenopausal schizophrenia women?
    González-Rodríguez A, Bernardo M, Penadés R, Arias B, Ruiz Cortés V, Seeman MV, Catalán R.
    Arch Womens Ment Health; 2017 Oct 01; 20(5):613-620. PubMed ID: 28702774
    [Abstract] [Full Text] [Related]

  • 17. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU, Mandelli L, Han C, Ham BJ, Masand PS, Patkar AA, Steffens DC, De Ronchi D, Serretti A.
    Neuro Endocrinol Lett; 2008 Aug 01; 29(4):500-6. PubMed ID: 18766158
    [Abstract] [Full Text] [Related]

  • 18. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
    Murphy N, Strickler HD, Stanczyk FZ, Xue X, Wassertheil-Smoller S, Rohan TE, Ho GY, Anderson GL, Potter JD, Gunter MJ.
    J Natl Cancer Inst; 2015 Oct 01; 107(10):. PubMed ID: 26232761
    [Abstract] [Full Text] [Related]

  • 19. Hormone levels and cognitive function in postmenopausal midlife women.
    Ryan J, Stanczyk FZ, Dennerstein L, Mack WJ, Clark MS, Szoeke C, Kildea D, Henderson VW.
    Neurobiol Aging; 2012 Jul 01; 33(7):1138-47. PubMed ID: 22607736
    [Abstract] [Full Text] [Related]

  • 20. Association of follicle-stimulating hormone levels and risk of type 2 diabetes in older postmenopausal women.
    Bertone-Johnson ER, Virtanen JK, Niskanen L, Nurmi T, Ronkainen K, Voutilainen S, Mursu J, Kauhanen J, Tuomainen TP.
    Menopause; 2017 Jul 01; 24(7):796-802. PubMed ID: 28141661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.